ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0876

Metabolomic Analysis Reveals Associations Between Calcium Crystals and Metabolites in Osteoarthritic Synovial Tissue

Nathan Argel1, Sina Stücker2, Adnan Cutuk3, Robert Meyer3, Nancy Lane4, Jessica Bertrand2, Monica Guma3 and Jessica Murillo-Saich1, 1Department of Medicine, University of California San Diego, La Jolla, CA, 2Department of Orthopaedic Surgery, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany, 3San Diego VA Healthcare Service, La Jolla, CA, 4University of California, Hillsborough, CA

Meeting: ACR Convergence 2023

Keywords: metabolomics, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0859–0885) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Emerging research suggests that synovial inflammation and metabolic alterations are involved in the progression of osteoarthritis (OA). Additionally, the presence of calcium-containing crystals (CC), such as basic calcium phosphate (BCP) and calcium pyrophosphates (CPP) crystals, has been implicated in the development of OA, potentially contributing to inflammatory responses and pain. However, our understanding of the impact of CC on synovial tissue (ST) in OA remains limited. Therefore, the aim of this study is to investigate the relationship between synovial CC, histological composition, pain as well as the synovial metabolic profile in OA.

Methods: A total of 28 ST samples were collected from patients diagnosed with OA during total joint replacement surgeries. The ST samples were either fixed in formalin for subsequent histological analysis, or snap-frozen for metabolomic analysis. The histological assessment of ST samples was performed using the Krenn histopathological synovitis score, which categorized the samples into two groups: inflammation grade 0-I and inflammation grade II-III. Synovial CD68 positive cells and synovial area containing CC (%Ca++) were assessed by immunohistochemistry and Von Kossa staining respectively, and semi-quantified using Image J. The severity of OA disease was evaluated using the Western Ontario and McMaster Universities Arthritis Index (WOMAC). Nuclear Magnetic Resonance (NMR) spectra of the ST samples were acquired using a 600 MHz Bruker Avance III spectrometer with 1H-NMR. The Chenomx NMR Suite 8.5 professional software was employed for metabolite identification and quantification(μM). For statistical analysis, MetaboAnalyst 5.0, SPSS v26, and R Studio software were utilized.

Results: 13 samples with inflammation grade 0-I and 15 samples with inflammation grade II-III samples were included. There were no significant differences observed in the synovial area containing CC (%Ca++) between the two inflammation groups (p=0.48). Furthermore, no correlation was found between %Ca++ and CD68 expression (p=0.84). However, WOMAC scores showed a positive correlation with %Ca++ (Figure 1A-B). Regarding metabolites associated with %Ca++, we observed a positive association between pyruvate and %Ca++ (r=0.43, p=0.02) and a tendency for a positive correlation between succinate and %Ca++ (r=0.30, p=0.13). However, metabolites such as choline and glucose did not show any correlation with %Ca++ in ST (Figure 2A). Interestingly, we also found positive correlations between %Ca++ and citrate (r=0.62, p< 0.01), creatinine (r=0.67, p< 0.01), dimethylamine (r=0.77, p< 0.01), and sn-glycero-3-phosphocholine (r=0.43, p=0.02) (Figure 2B).

Conclusion: Our findings provide evidence supporting the association between synovial CC and the pain phenotype in OA. Although no direct correlation between inflammation and %Ca++ was observed, our results suggest that these crystals may contribute to metabolic alterations in the ST. Further investigations are warranted to elucidate whether the presence of CC in OA triggers pain and to identify the underlying metabolic pathways.

Supporting image 1

Figure 1. A) Scatter plot showing Pearson correlation between %Ca++ in synovial tissue and total WOMAC. B) Pearson correlation between the %Ca++ in synovial tissue and age, painDETECT and WOMAC scores.

Supporting image 2

Figure 2. Scatter plot showing Pearson correlation between %Ca++ in synovial tissue and A) metabolites associated to inflammation and B) other metabolites statistically significant.


Disclosures: N. Argel: None; S. Stücker: None; A. Cutuk: None; R. Meyer: None; N. Lane: None; J. Bertrand: None; M. Guma: Genentech, 5, Gilead, 5, Novartis, 5, Pfizer, 5; J. Murillo-Saich: None.

To cite this abstract in AMA style:

Argel N, Stücker S, Cutuk A, Meyer R, Lane N, Bertrand J, Guma M, Murillo-Saich J. Metabolomic Analysis Reveals Associations Between Calcium Crystals and Metabolites in Osteoarthritic Synovial Tissue [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/metabolomic-analysis-reveals-associations-between-calcium-crystals-and-metabolites-in-osteoarthritic-synovial-tissue/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/metabolomic-analysis-reveals-associations-between-calcium-crystals-and-metabolites-in-osteoarthritic-synovial-tissue/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology